What is Omacor?
Lovaza is a brand name prescription drug. The capsule sold by GlaxoSmithKline but developed by Reliant Pharmaceuticals, contains esterified fatty acid ethyl esters and is described in detail in US Patent 5,656,667. Pronova BioPharma is the innovator company for the APIs in Lovaza/Omacor. It is synthesized from fish body oils, typically from oily fish such as mackerel and anchovy. It is approved by the FDA (Food and Drug Administration) to lower very high triglyceride levels. It is a pro-drug that is metabolized into Omega-3 fatty acids and ethanol. It is not a dietary supplement and has been wrongly called "fish oil" which it is clearly not. It is a pharmaceutical drug with the two main active pharmaceutical ingredients (API) being EPA-ethyl ester and DHA-ethyl ester. After the esterification process, molecular distillation is used to decrease organic pollutants, methylmercury, arsenic, or other pollutants that are often seen in the world's oceans. Each capsule weighs (drug product) 1.43089 g and contains 0.99461 grams of liquid. This is composed of 465 mg EPA ethyl ester and 375 mg DHA ethyl ester. There is an additional approximately 130 mg of other omega-3 fatty acid ethyl esters.
Lovaza is named Omacor in Europe (and this name was once used in the US).